Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Grant A.
Grant A. Colton, Sr., Butler, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090020163 | Siphon Breaker - A siphon breaker includes a housing having a gas inlet and a gas outlet. The siphon breaker includes a stop valve adapted to transition from a closed position in which gas is substantially prevented from entering the gas inlet, and an open position in which gas is introduced into the gas inlet. The siphon breaker includes a control valve having a control valve gas inlet, a control valve gas outlet, and an electrically operated actuator. The control valve is adapted to transition from a closed position in which gas is substantially prevented from entering the control valve gas inlet, to an open position in which gas is through the control valve gas inlet. | 01-22-2009 |
Grant A. Lugas, Elyria, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20110097983 | Vent Apparatus - A vent apparatus ( | 04-28-2011 |
Grant A. Mcnaughton-Smith, Morrisville, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20100190746 | QUINAZOLINONES AS POTASSIUM CHANNEL MODULATORS - Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazolinone, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety and motor neuron diseases) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions. | 07-29-2010 |